Downregulation of miR-219 enhances brain-derived neurotrophic factor production in mouse dorsal root ganglia to mediate morphine analgesic tolerance by upregulating CaMKIIγ

Mol Pain. 2016 Sep 5:12:1744806916666283. doi: 10.1177/1744806916666283. Print 2016.

Abstract

Background: Increasing evidence suggests that microRNAs are functionally involved in the initiation and maintenance of pain hypersensitivity, including chronic morphine analgesic tolerance, through the posttranscriptional regulation of pain-related genes. We have previously demonstrated that miR-219 regulates inflammatory pain in the spinal cord by targeting calcium/calmodulin-dependent protein kinase II gamma (CaMKIIγ). However, whether miR-219 regulates CaMKIIγ expression in the dorsal root ganglia to mediate morphine tolerance remains unclear.

Results: MiR-219 expression was downregulated and CaMKIIγ expression was upregulated in mouse dorsal root ganglia following chronic morphine treatment. The changes in miR-219 and CaMKIIγ expression closely correlated with the development of morphine tolerance, which was measured using the reduction of percentage of maximum potential efficiency to thermal stimuli. Morphine tolerance was markedly delayed by upregulating miR-219 expression using miR-219 mimics or downregulating CaMKIIγ expression using CaMKIIγ small interfering RNA. The protein and mRNA expression of brain-derived neurotrophic factor were also induced in dorsal root ganglia by prolonged morphine exposure in a time-dependent manner, which were transcriptionally regulated by miR-219 and CaMKIIγ. Scavenging brain-derived neurotrophic factor via tyrosine receptor kinase B-Fc partially attenuated morphine tolerance. Moreover, functional inhibition of miR-219 via miR-219-sponge in naive mice elicited thermal hyperalgesia and spinal neuronal sensitization, which were both suppressed by CaMKIIγ small interfering RNA or tyrosine receptor kinase B-Fc.

Conclusions: These results demonstrate that miR-219 contributes to the development of chronic tolerance to morphine analgesia in mouse dorsal root ganglia by targeting CaMKIIγ and enhancing CaMKIIγ-dependent brain-derived neurotrophic factor expression.

Keywords: CaMKIIγ; Morphine tolerance; brain-derived neurotrophic factor; dorsal root ganglia; hyperalgesia; miR-219.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / pharmacology
  • Animals
  • Brain-Derived Neurotrophic Factor / metabolism*
  • CREB-Binding Protein / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / genetics
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
  • Disease Models, Animal
  • Drug Tolerance / physiology*
  • Freund's Adjuvant / toxicity
  • Ganglia, Spinal / drug effects*
  • Ganglia, Spinal / metabolism
  • Gene Expression Regulation / drug effects*
  • Gene Expression Regulation / physiology
  • Hyperalgesia / drug therapy
  • Hyperalgesia / etiology
  • Hyperalgesia / metabolism
  • Male
  • Mice
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Morphine / pharmacology*
  • Pain / chemically induced
  • Pain / drug therapy
  • Proto-Oncogene Proteins c-fos / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / pharmacology
  • Signal Transduction / drug effects
  • Time Factors

Substances

  • Analgesics, Opioid
  • Brain-Derived Neurotrophic Factor
  • MIRN219 microRNA, mouse
  • MicroRNAs
  • Proto-Oncogene Proteins c-fos
  • RNA, Small Interfering
  • Morphine
  • Freund's Adjuvant
  • CREB-Binding Protein
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2